Group One Trading
AMAM

Group One Trading’s Ambrx Biopharma Inc AMAM Stock Holding History

Group One Trading’s Portfolio AMAM Stock Details AMAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-2,155
Closed -$24.5K – 8402
2023
Q3 		$24.8K Buy
+2,155
New +$29.4K ﹤0.01% 5716
2023
Q2 		– Sell
-3,345
Closed -$42.1K – 8361
2023
Q1 		$29.8K Buy
+3,345
New +$16.8K ﹤0.01% 5243

Group One Trading's AMAM Position: Q4 2023 in Review

Group One Trading sold out of Ambrx Biopharma Inc (AMAM) in Q4 2023, closing a stake of 2,155 shares — an estimated $24.5K sold.

Group One Trading first reported a position in AMAM in Q1 2023 and held it in 2 quarters. The position peaked at $29.8K in Q1 2023. 68 funds tracked by Wall St. Rank hold AMAM as of Q4 2023.

  • Group One Trading reported no remaining Ambrx Biopharma Inc position as of Q4 2023 after selling out during the quarter.
  • Group One Trading sold 2,155 Ambrx Biopharma Inc shares in Q4 2023, an estimated $24.5K.
  • Group One Trading first reported a position in Ambrx Biopharma Inc in Q1 2023 and held it in 2 quarters.
  • Group One Trading's Ambrx Biopharma Inc position peaked at $29.8K in Q1 2023.
  • 68 funds tracked by Wall St. Rank held Ambrx Biopharma Inc as of Q4 2023.

Based on Group One Trading's 13F filing for Q4 2023, filed 14 Feb 2024.